NCT01798264View on ClinicalTrials.gov

Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Type 2 Diabetes
Interventions
DRUG

ITCA 650 (exenatide in DUROS)

Trial Locations (3)

33169

Miami Gardens

45212

Medpace Clinical Pharmacology Unit, Cincinnati

78229

dGd Research, San Antonio

Sponsors
All Listed Sponsors
lead

Intarcia Therapeutics

INDUSTRY